5 New Stock Picks of Billionaire Ray Dalio

In this article, we discuss the 5 new stock picks of billionaire Ray Dalio. If you want to read our detailed analysis of these stocks, go directly to the 10 New Stock Picks of Billionaire Ray Dalio.

5. Moderna, Inc. (NASDAQ:MRNA)

Number of Hedge Fund Holders: 37  

Moderna, Inc. (NASDAQ:MRNA) is a biotech firm that develops vaccines for people with infectious diseases. Regulatory filings show that Bridgewater Associates owned 8,309 shares in the company at the end of the third quarter of 2021 worth over $3.1 million, representing a very small portion of the portfolio. 

On November 8, investment advisory Wolfe Research initiated coverage of Moderna, Inc. (NASDAQ:MRNA) stock with an Outperform rating and a price target of $304. Analyst Andrew Galler issued the ratings update. 

At the end of the second quarter of 2021, 37 hedge funds in the database of Insider Monkey held stakes worth $5.7 billion in Moderna, Inc. (NASDAQ:MRNA), down from 39 in the preceding quarter worth $1.6 billion. 

In its Q2 2021 investor letter, Baillie Gifford, an asset management firm, highlighted a few stocks and Moderna, Inc. (NASDAQ:MRNA) was one of them. Here is what the fund said:

“Among the top contributors to Fund performance in the second quarter was Moderna. Moderna has just reported its first profitable quarter in the company’s history – net income for the most recent quarter was $1.2 billion. It reported revenue of $1.9 billion, an impressive increase compared to $8 million a year ago, driven by the sales of its Covid-19 vaccine. Moderna is expecting to deliver up to 1 billion vaccine doses in 2021 and is in discussions to increase global supply to governments around the world. Our long-term focus remains on the transformational potential of Moderna’s technology and its ability to address different diseases.”